Yesterday QDX HealthID announced a partnership with Innova Medical Group (IMG) to implement IMG antigen, antibody and PCR swab tests into its blockchain-based platform for COVID-19 immunity passports.
QDX HealthID was created earlier this year as a subsidiary of the US-based quantum dot producer Quantum Materials Corp (QMC). The platform, which is currently in beta testing, seeks to address the issue of unreliable or inauthentic health data. Often, these are recorded on paper, making forgery and tampering a major issue.
The QDX HealthID solution uses distributed ledger technology (DLT) to immutably and securely store authentication data for COVID-19 immunity passports which are used to show whether an individual has the virus. More specifically, what’s stored is the authenticity of the patient’s identity, the test, and the person administering the test.
Article continues …
Want the full story? Pro subscribers get complete articles, exclusive industry analysis, and early access to legislative updates that keep you ahead of the competition. Join the professionals who are choosing deeper insights over surface level news.
